Correction: Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 23 (9472-9477) DOI: 10.1073/pnas.1101296108);Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 23, 2011, Pages 9472-9477

  Koide, Masahiro ^a   Ikeda, Koji ^a   Akakabe, Yoshiki ^a   Kitamura, Youhei ^a   Ueyama, Tomomi ^a   Matoba, Satoaki ^a   Yamada, Hiroyuki ^a   Okigaki, Mitsuhiko ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; APOPTOSIS REGULATOR THROUGH MODULATING IAP PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLEEDING; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE DELETION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

MUS;

EID: 79959346367     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1506580112     Document Type: Erratum

References (34)

1. Hur J, et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293. (Pubitemid 38197580)
2. Yoon C-H, et al. (2005) Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation 112:1618-1627. (Pubitemid 41324524)
3. Zisch A-H (2004) Tissue engineering of angiogenesis with autologous endothelial progenitor cells. Curr Opin Biotechnol 15:424-429.
4. Lin Y, Weisdorf D-J, Solovey A, Hebbel R-P (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77. (Pubitemid 30036389)
5. Murayama T, et al. (2002) Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30:967-972. (Pubitemid 34838899)
6. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6, Suppl 16):15-18.
7. Gao D, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319:195-198.
8. Shaked Y, et al. (2006) Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313:1785-1787. (Pubitemid 44454154)
9. Tonnesen M-G, Feng X, Clark R-A (2000) Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5:40-46. (Pubitemid 32044088)
10. Shantsila E, Watson T, Lip G-Y (2007) Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49:741-752.
11. Masuda H, Asahara T (2003) Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58:390-398. (Pubitemid 36570397)
12. Losordo D-W, Dimmeler S (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part II: Cell-based therapies. Circulation 109:2692-2697.
13. Manning B-D, Cantley L-C (2007) AKT/PKB signaling: Navigating downstream. Cell 129:1261-1274.
14. Shiojima I, Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90:1243-1250. (Pubitemid 34787405)
15. Gregorian C, et al. (2009) Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci 29:1874-1886.
16. Bi L, Okabe I, Bernard D-J, Wynshaw-Boris A, Nussbaum R-L (1999) Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem 274:10963-10968.
17. Jiang B-H, Zheng J-Z, Aoki M, Vogt P-K (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97:1749-1753. (Pubitemid 30118514)
18. Hamada K, et al. (2005) The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19:2054-2065. (Pubitemid 41247962)
19. Morello F, Perino A, Hirsch E (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82:261-271.
20. Ikeda K, et al. (2009) Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc Natl Acad Sci USA 106:8227-8232.
21. Hur J, et al. (2007) Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25:1769-1778. (Pubitemid 47121856)
22. Dubois N-A, Kolpack L-C, Wang R, Azizkhan R-G, Bautch V-L (1991) Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp Cell Res 196:302-313.
23. Salmena L, Carracedo A, Pandolfi P-P (2008) Tenets of PTEN tumor suppression. Cell 133:403-414. (Pubitemid 351622014)
24. Xia H, et al. (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176:2626-2637.
25. Vazquez F, et al. (2001) Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276:48627-48630.
26. Rahdar M, et al. (2009) A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci USA 106:480-485.
27. Odriozola L, Singh G, Hoang T, Chan A-M (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem 282:23306-23315. (Pubitemid 47311930)
28. Wu Y, et al. (2000) Interactionof the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem275:21477-21485. (Pubitemid 30481851)
29. Wu X, et al. (2000) Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci USA 97:4233-4238. (Pubitemid 30226116)
30. Kotelevets L, et al. (2005) Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 19:115-117. (Pubitemid 40069936)
31. Takahashi Y, Morales F-C, Kreimann E-L, Georgescu M-M (2006) PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25:910-920. (Pubitemid 43292451)
32. Sumitomo M, et al. (2004) Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5:67-78. (Pubitemid 38121597)
33. Stambolic V, et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39. (Pubitemid 28458022)
34. Duval H, et al. (2007) Vascular development is disrupted by endothelial cell-specific expression of the anti-apoptotic protein Bcl-2. Angiogenesis 10:55-68. (Pubitemid 46356219)